Stock screenerAll disclosures →
EDGAR →
AMRN
Conviction 1HealthcareScan · Mon, Aug 10, 2026AMRN$14.16-1.39%
ResistanceSupportVol 14Vol MA14 51.37K
May 11May 28Jun 16Jul 6Jul 23Aug 10
Price14.16
Change-1.39%
Gap-1.81%
Rel volume0.58×
Avg volume55.9K
Avg $ vol787.32K
SMA 2014.07
SMA 5014.79
SMA 20015.02
Price vs 50-4.27%
Price vs 200-5.73%
MA stackbearish
50/200 cross—
Supertrenddown · 15.33
RSI (14)45
MACD hist0.07
MACD crossbull · 6d
Stoch %K / %D61 / 70
ADX (14)14
+DI / −DI16 / 16
RSI divergence—
MACD divergence—
ATR %+3.56%
ADR %3.34%
52w high20.25
52w low13.50
From 52w high-30.07%
Above 52w low+4.89%
New 52w highNo
SqueezeOff
Bollinger width8.14%
%B0.57
Donchian pos51.49%
Donchian high14.81
Donchian low13.47
AVWAP (52w high)15.26
vs AVWAP high-7.21%
AVWAP (52w low)14.81
vs AVWAP low-4.39%
OBV trendFlat
Chaikin MF (20)-0.12
Today vs 20d0.58×
Avg vol (14d)51.37K
Avg vol (20d)55.9K
Avg $ vol (20d)787.32K
Market cap—
RS 3m (vs SPY)-8.93%
RS 6m (vs SPY)-12.20%
RS line new highNo
Trend template0/8
Technical rank24.7
1 week+0.14%
1 month-4.84%
3 months-5.91%
6 months-4.00%
1 year-6.23%
YTD+3.21%
P/E-0.14
P/B0.01
P/S0.03
P/FCF0.84
EPS-0.0900
Div yield—
ROE-8.75%
ROA-6.21%
Debt/Eq0.02
Current3.67
EV/EBITDA2.58
Gross margin56.57%
Net margin-18.16%
Rev growth-6.55%
EPS growth52.79%
Price target—
Target upside—
Analyst rating—
Institutional—
Ent. value-129.23M
Revenue42.21M
Net income-7.65M
Gross profit14.99M
Free cash flow6.48M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out20.97M
Employees80
ListedThu, Apr 1, 1993
Free float—
Float %—
Short interest—
Days to cover—
Short volume—
Squeeze score—
Next earnings—
EPS forecast—
Last EPS vs est—
Last surprise—
Setup gradeD
Conviction1 / 100
Pattern quality—
Tech rank24.7 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance17.11
Support13.49
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Jun 30, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in AMRN
No recent disclosed trades by Congress in AMRN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in AMRN · 7 buys · 3 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Keenan David Paul EVP, Chief Operating Officer · American Depositary Shares · 2026-07-01 | Exercise | 3.69K | — | 2026-07-01 | 2026-07-15 |
Keenan David Paul EVP, Chief Operating Officer · American Depositary Shares · 2026-07-01 | Tax | 1.93K | $31K | 2026-07-01 | 2026-07-15 |
Keenan David Paul EVP, Chief Operating Officer · Restricted Stock Unit · 2026-07-01 | Grant | 3.69K | — | 2026-07-01 | 2026-07-15 |
Ketchum Steven B EVP, Chief Scientific Officer · American Depositary Shares · 2026-07-01 | Exercise | 3.69K | — | 2026-07-01 | 2026-07-15 |
Ketchum Steven B EVP, Chief Scientific Officer · American Depositary Shares · 2026-07-01 | Tax | 1.89K | $30K | 2026-07-01 | 2026-07-15 |
Ketchum Steven B EVP, Chief Scientific Officer · Restricted Stock Unit · 2026-07-01 | Grant | 3.69K | — | 2026-07-01 | 2026-07-15 |
Provoost Jonathan EVP, Chief Legal Officer · American Depositary Shares · 2026-07-01 | Exercise | 3.69K | — | 2026-07-01 | 2026-07-15 |
Provoost Jonathan EVP, Chief Legal Officer · American Depositary Shares · 2026-07-01 | Tax | 1.26K | $20K | 2026-07-01 | 2026-07-15 |
Provoost Jonathan EVP, Chief Legal Officer · Restricted Stock Unit · 2026-07-01 | Grant | 3.69K | — | 2026-07-01 | 2026-07-15 |
Fishman Peter L. SVP, CFO · American Depositary Shares · 2026-07-01 | Exercise | 2.45K | — | 2026-07-01 | 2026-07-15 |
SEC filings
EDGAR filings in AMRN · 2 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.
Start free — 14-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.